Abstract
Angiogenesis, neovascularization from pre-existing vessels, is a key step in tumor growth and metastasis, and anti-angiogenic agents that can interfere with these essential steps of cancer development are a promising strategy for human cancer treatment. In this study, we characterized the anti-angiogenic effects of Coptis japonica Makino extract (CJME) and its mechanism of action. CJME significantly inhibited the proliferation, migration, and invasion of vascular endothelial growth factor (VEGF)-stimulated HUVECs. Furthermore, CJME suppressed VEGF-induced tube formation in vitro and VEGF-induced microvessel sprouting ex vivo. According to our study, CJME blocked VEGF-induced cell cycle transition in G1. CJME decreased expression of cell cycle-regulated proteins, including Cyclin D, Cyclin E, Cdk2, and Cdk4 in response to VEGF. Taken together, the results of our study indicate that CJME suppresses VEGF-induced angiogenic events such as proliferation, migration, and tube formation via cell cycle arrest in G1.
Keywords:
Coptis japonica Makino; angiogenesis; human umbilical vein endothelial cells (HUVEC); vascular endothelial growth factor (VEGF).
MeSH terms
-
Angiogenesis Inhibitors / isolation & purification
-
Angiogenesis Inhibitors / pharmacology*
-
Animals
-
Cell Movement / drug effects
-
Cell Proliferation / drug effects
-
Cell Survival / drug effects
-
Coptis / chemistry*
-
Cyclin D / antagonists & inhibitors
-
Cyclin D / genetics
-
Cyclin D / metabolism
-
Cyclin E / antagonists & inhibitors
-
Cyclin E / genetics
-
Cyclin E / metabolism
-
Cyclin-Dependent Kinase 2 / antagonists & inhibitors
-
Cyclin-Dependent Kinase 2 / genetics
-
Cyclin-Dependent Kinase 2 / metabolism
-
Cyclin-Dependent Kinase 4 / antagonists & inhibitors
-
Cyclin-Dependent Kinase 4 / genetics
-
Cyclin-Dependent Kinase 4 / metabolism
-
G1 Phase Cell Cycle Checkpoints / drug effects*
-
G1 Phase Cell Cycle Checkpoints / genetics
-
Gene Expression Regulation / drug effects*
-
Human Umbilical Vein Endothelial Cells
-
Humans
-
Male
-
Neovascularization, Pathologic / genetics
-
Neovascularization, Pathologic / metabolism
-
Neovascularization, Pathologic / prevention & control*
-
Plant Extracts / chemistry
-
Rats
-
Rats, Sprague-Dawley
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors*
-
Vascular Endothelial Growth Factor A / pharmacology
Substances
-
Angiogenesis Inhibitors
-
Cyclin D
-
Cyclin E
-
Plant Extracts
-
Vascular Endothelial Growth Factor A
-
CDK2 protein, human
-
CDK4 protein, human
-
Cyclin-Dependent Kinase 2
-
Cyclin-Dependent Kinase 4